BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dallas-Based Biopharmaceutical Company, Cumbre, Inc. Announces Barry Hafkin M.D. As President And CEO


10/25/2005 2:28:17 PM

"Dallas Biotech Attracts Pharmaceutical Veteran" Dallas , Texas , October 24, 2005 -- Cumbre Inc, a Dallas-based biopharmaceutical company, announced today that Barry Hafkin M.D. has joined the company as President and CEO. Established in 2001, Cumbre is focused on the discovery and development of antibiotics for the treatment of patients with very severe and chronic infections. The company plans to initiate clinical trials of a first in a novel class of antibiotics in the 2 nd quarter of 2006. The novel antibiotic is designed to improve outcomes in patients with infections caused by Methicillin Resistant Staphylococcus aureaus (MRSA). Dr. Hafkin joins Cumbre with years of success in the development and registration of both antibiotic and antiviral compounds in both large pharmaceutical and biotech environments. "We are excited to have such an experienced leader join the Cumbre team," said Dr. Steve McKnight, a Cumbre founder and board member. "The company continues to position itself well with exciting scientific progress and now has the clinical expertise needed for successful trials."


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES